Osaic Holdings’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-111
Closed -$13.4K 7686
2023
Q1
$13.4K Sell
111
-250
-69% -$28.8K ﹤0.01% 5806
2022
Q4
$41K Sell
361
-417
-54% -$46K ﹤0.01% 5080
2022
Q3
$79K Hold
778
﹤0.01% 4570
2022
Q2
$79K Buy
+778
New +$84.8K ﹤0.01% 4610
2022
Q1
Sell
-705
Closed -$81K 7685
2021
Q4
$81K Buy
+705
New +$80.4K ﹤0.01% 4758
2020
Q4
Sell
-347
Closed -$39K 6678
2020
Q3
$39K Sell
347
-100
-22% -$11.2K ﹤0.01% 4493
2020
Q2
$47K Buy
+447
New +$47.9K ﹤0.01% 4242

Other funds holding BSX.PRA

Osaic Holdings's BSX.PRA Position: Q2 2023 in Review

Osaic Holdings sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 111 shares — an estimated $13.4K sold.

Osaic Holdings first reported a position in BSX.PRA in Q2 2020 and held it in 7 quarters. The position peaked at $81K in Q4 2021. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • Osaic Holdings reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • Osaic Holdings sold 111 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $13.4K.
  • Osaic Holdings first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 7 quarters.
  • Osaic Holdings's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $81K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.